Iwase H, Greenman J M, Barnes D M, Bobrow L, Hodgson S, Mathew C G
Imperial Cancer Research Fund (ICRF), Guy's Hospital, London, UK.
Br J Cancer. 1995 Mar;71(3):448-50. doi: 10.1038/bjc.1995.91.
DNA from 67 primary breast carcinoma biopsies has been examined for loss of heterozygosity (LOH) using the microsatellite (TA)n repeat marker positioned 1 kb upstream of the oestrogen receptor (ER) gene. Forty-seven (70.1%) of the cases were informative; nine of these (19.1%) were positive for LOH. In three of the nine cases, there was total loss, and in the other six cases there was a marked reduction in the intensity of signal from one allele. LOH correlated weakly with histological grade and age, but not with ER status. This result suggests that LOH of the ER gene does not have an important role in the lack of ER function in breast cancer tissues.
利用位于雌激素受体(ER)基因上游1 kb处的微卫星(TA)n重复标记,对67例原发性乳腺癌活检组织的DNA进行杂合性缺失(LOH)检测。47例(70.1%)病例具有信息性;其中9例(19.1%)LOH呈阳性。在这9例中的3例中,出现了完全缺失,在另外6例中,一个等位基因的信号强度明显降低。LOH与组织学分级和年龄呈弱相关,但与ER状态无关。该结果表明,ER基因的LOH在乳腺癌组织中ER功能缺失方面不发挥重要作用。